Controversies in medicine: redefining the diagnosis of type 1 diabetes

Jennifer J Couper and Leonard C Harrison
Med J Aust 2019; 211 (4): . || doi: 10.5694/mja2.50284
Published online: 19 August 2019

Diagnosis of autoimmune β-cell disorder before end-stage clinical type 1 diabetes is a key step towards the prevention of this disease

  • Jennifer J Couper1,2
  • Leonard C Harrison3

  • 1 Women's and Children's Hospital, Adelaide, SA
  • 2 University of Adelaide, Adelaide, SA
  • 3 Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC


We acknowledge the contributions to the manuscript of Megan Penno and the community support and perspective provided by Juvenile Diabetes Research Foundation Australia, the recipient of the Australian Research Council Special Research Initiative in Type 1 Diabetes. Leonard Harrison was supported by a National Health and Medical Research Council Senior Principal Research Fellowship (1080887).

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.